Clear and present data: identifying barriers to clinical trial transparency
What’s standing in the way of researchers adopting good practices on clinical trial data sharing and transparency?
Data sharing and reporting still suboptimal in vaccine trials
A recent analysis of randomised controlled vaccine trials suggests there are still improvements to be made.
WHO mandates health-related data sharing
Learn all about the new WHO data sharing policy and their practical guidance on data sharing plans.
How common is data sharing for COVID-19 preprints?
An analysis of early COVID-19 preprints identified low uptake of data sharing statements and making data accessible.
The reality of data sharing behaviour: do researchers share their data as promised?
A recent study revealed that many researchers fail to comply with their data sharing statement.
NIH bid to tackle reproducibility crisis – is data sharing the answer?
Read about the upcoming NIH requirement to include a data management and sharing plan in all grant applications for projects collecting scientific data.
Are data availability statements slowing down publication processes?
Read the results of a pilot study on the impact of data availability statements on publication workflows.
WHO and ICMRA announce a joint statement on data transparency and integrity
Read about their call to action for the pharmaceutical industry to increase sharing of clinical trial data.
Open science is accelerated as a result of the COVID-19 pandemic
Find out how COVID-19 has benefited data sharing and what your organisation can do to advance open science from the State of Open Data 2020 report.
Acceleration of research and implications for research transparency: our summary of the third Biomedical Transparency Summit series webinar
The third webinar in the Biomedical Transparency Summit Series considered the impact of COVID-19 on research transparency and data sharing.